NDC 80425-0237-01 - Diclofenac Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0237
- Requested NDC
- 80425-0237-01
- Package NDCs from labels
- 80425-0237-1, 80425-0237-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Diclofenac Sodium - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0237-1 | Diclofenac Sodium | 150 mL in 1 BOTTLE | SOLUTION | 150 | 4 | |
| 80425-0237-1 | Diclofenac Sodium | 1 in 1 CARTON | SOLUTION | 1 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0237 | DICLOFENAC SODIUM SOLUTION [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 4 | Current NDC, 2 package rows | 20250102_f1896c84-b18a-d49d-e053-2995a90aaab3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0237-1 | ML - Milliliter | 80425-0237 | e028fbd8-98bc-4f4a-97fa-fd08d74407b3 | 1 | 2023-03-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diclofenac Sodium | DICLOFENAC SODIUM TOPICAL | Alembic Pharmaceuticals Limited | 11adfe0f-e774-4ccf-8a57-0c7d47aeb0dd | 2025-03-04 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Voltaren Arthritis Pain | DICLOFENAC SODIUM | Haleon US Holdings LLC | 30a94282-0892-442a-aa10-6525cbd4fe88 | 2025-02-11 | Warnings | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Bryant Ranch Prepack | af480e78-ff65-4709-af26-c430aefb77d6 | 2025-02-10 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Asclemed USA, Inc. | 5508f80d-5f11-4959-8e42-9055f0169cfc | 2025-02-08 | Boxed warning, Warnings, Adverse reactions | 857700 QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | NuCare Pharmaceuticals,Inc. | 0d1d19e5-4ffe-af95-e063-6394a90a7abf | 2025-02-03 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Proficient Rx LP | d70fcd8e-a72b-41ef-ac26-e0f2f279f062 | 2025-02-01 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Actavis Pharma, Inc. | 74169b2d-ac56-4757-86c4-cdcfcd5f4eb5 | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Coupler LLC | 2ce0741a-7bc7-8aec-e063-6294a90ae9ef | 2025-01-29 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium and Misoprostol | DICLOFENAC SODIUM AND MISOPROSTOL | Bryant Ranch Prepack | d6671b66-00ad-4949-b51a-36e1130b1cb5 | 2025-01-29 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Bryant Ranch Prepack | 49013aad-475c-4efb-84c6-15a5d4664fbf | 2025-01-29 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Aspercreme Arthritis | DICLOFENAC SODIUM | Chattem, Inc. | 762b7ef4-166c-43b8-9acd-2b9e7fa0bf36 | 2025-01-28 | Warnings | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Direct_Rx | f80b0b95-f4da-2d6c-e053-6294a90acf92 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 857700 QTG126297Q |
| Diclofenac Sodium Gel | DICLOFENAC SODIUM GEL | Direct_Rx | fce9b3eb-ae79-a090-e053-6294a90ad20e | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Direct_Rx | 0c41977f-8dad-1d26-e063-6294a90a9b22 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | ANDA206116 857700 QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | DIRECT RX | a5b33bf7-8113-9c54-e053-2995a90a79d8 | 2025-01-20 | Boxed warning, Warnings, Adverse reactions | ANDA206116 857700 QTG126297Q |
| Diclofenac sodium | DICLOFENAC SODIUM | Alembic Pharmaceuticals Inc. | 02e90e33-384f-4e29-b508-2503def22214 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | NuCare Pharmaceuticals,Inc. | 62edf474-9c16-d535-e053-2991aa0a4a09 | 2025-01-14 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium 1.5% | DICLOFENAC SODIUM TOPICAL | Preferred Pharmaceuticals Inc. | dbcd42cf-d44a-4d47-9149-66ffcf9a0587 | 2025-01-13 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac sodium | DICLOFENAC SODIUM | Preferred Pharmaceuticals Inc. | 81bfeada-6589-4528-bea5-059ab0fabb43 | 2025-01-13 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | NorthStar Rx LLC | fd467c1a-6463-4d92-9960-3e308c733edb | 2025-01-10 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.